These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25378593)

  • 21. TLR1, TLR2, and TLR6 gene polymorphisms are associated with increased susceptibility to complicated skin and skin structure infections.
    Stappers MH; Thys Y; Oosting M; Plantinga TS; Ioana M; Reimnitz P; Mouton JW; Netea MG; Joosten LA; Gyssens IC
    J Infect Dis; 2014 Jul; 210(2):311-8. PubMed ID: 24511099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effector T cells boost regulatory T cell expansion by IL-2, TNF, OX40, and plasmacytoid dendritic cells depending on the immune context.
    Baeyens A; Saadoun D; Billiard F; Rouers A; Grégoire S; Zaragoza B; Grinberg-Bleyer Y; Marodon G; Piaggio E; Salomon BL
    J Immunol; 2015 Feb; 194(3):999-1010. PubMed ID: 25548233
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal structure of the TLR1-TLR2 heterodimer induced by binding of a tri-acylated lipopeptide.
    Jin MS; Kim SE; Heo JY; Lee ME; Kim HM; Paik SG; Lee H; Lee JO
    Cell; 2007 Sep; 130(6):1071-82. PubMed ID: 17889651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential but direct abolishment of human regulatory T cell suppressive capacity by various TLR2 ligands.
    Oberg HH; Ly TT; Ussat S; Meyer T; Kabelitz D; Wesch D
    J Immunol; 2010 May; 184(9):4733-40. PubMed ID: 20363971
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The polymorphism P315L of human toll-like receptor 1 impairs innate immune sensing of microbial cell wall components.
    Omueti KO; Mazur DJ; Thompson KS; Lyle EA; Tapping RI
    J Immunol; 2007 May; 178(10):6387-94. PubMed ID: 17475868
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of full length bovine TLR1 and functional characterization of lipopeptide recognition by bovine TLR2/1 heterodimer.
    Farhat K; Riekenberg S; Jung G; Wiesmüller KH; Jungi TW; Ulmer AJ
    Vet Res; 2010; 41(3):34. PubMed ID: 20167196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PD-1 upregulated on regulatory T cells during chronic virus infection enhances the suppression of CD8+ T cell immune response via the interaction with PD-L1 expressed on CD8+ T cells.
    Park HJ; Park JS; Jeong YH; Son J; Ban YH; Lee BH; Chen L; Chang J; Chung DH; Choi I; Ha SJ
    J Immunol; 2015 Jun; 194(12):5801-11. PubMed ID: 25934860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Distinct responses of two hepatocellular carcinoma cell lines of a similar origin to immunotherapies targeting regulatory or effector T cells.
    Nagayama Y; Hase W; Motoyoshi Y; Saitoh O; Sogawa R; Nakao K
    Oncol Rep; 2007 May; 17(5):1269-73. PubMed ID: 17390075
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling.
    Farhat K; Riekenberg S; Heine H; Debarry J; Lang R; Mages J; Buwitt-Beckmann U; Röschmann K; Jung G; Wiesmüller KH; Ulmer AJ
    J Leukoc Biol; 2008 Mar; 83(3):692-701. PubMed ID: 18056480
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The interplay of effector and regulatory T cells in cancer.
    Roychoudhuri R; Eil RL; Restifo NP
    Curr Opin Immunol; 2015 Apr; 33():101-11. PubMed ID: 25728990
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms in TLR1, TLR6 and TLR10 genes and the risk of Graves' disease.
    Xiao W; Liu Z; Lin J; Li J; Wu K; Ma Y; Gong Y; Liu Z
    Autoimmunity; 2015 Feb; 48(1):13-8. PubMed ID: 25028161
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toll-like Receptor 1 743 A>G, 1805 T>G & Toll-like Receptor 6 745 C>T gene polymorphism and tuberculosis: a case control study of north Indian population from Agra (India).
    Sinha E; Biswas SK; Mittal M; Bajaj B; Singh V; Arela N; Katoch VM; Mohanty KK
    Hum Immunol; 2014 Aug; 75(8):880-6. PubMed ID: 24984237
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tremelimumab (anti-CTLA4) mediates immune responses mainly by direct activation of T effector cells rather than by affecting T regulatory cells.
    Khan S; Burt DJ; Ralph C; Thistlethwaite FC; Hawkins RE; Elkord E
    Clin Immunol; 2011 Jan; 138(1):85-96. PubMed ID: 21056008
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interplay between mTOR and STAT5 signaling modulates the balance between regulatory and effective T cells.
    Shan J; Feng L; Sun G; Chen P; Zhou Y; Xia M; Li H; Li Y
    Immunobiology; 2015 Apr; 220(4):510-7. PubMed ID: 25468562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of IL-37 contributes to the immunosuppressive property of human CD4+CD25+ regulatory T cells.
    Shuai X; Wei-min L; Tong YL; Dong N; Sheng ZY; Yao YM
    Sci Rep; 2015 Sep; 5():14478. PubMed ID: 26411375
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis.
    Wurfel MM; Gordon AC; Holden TD; Radella F; Strout J; Kajikawa O; Ruzinski JT; Rona G; Black RA; Stratton S; Jarvik GP; Hajjar AM; Nickerson DA; Rieder M; Sevransky J; Maloney JP; Moss M; Martin G; Shanholtz C; Garcia JG; Gao L; Brower R; Barnes KC; Walley KR; Russell JA; Martin TR
    Am J Respir Crit Care Med; 2008 Oct; 178(7):710-20. PubMed ID: 18635889
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.
    Sharabi A; Lapter S; Mozes E
    J Autoimmun; 2010 Mar; 34(2):87-95. PubMed ID: 19596183
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced stabilization of atherosclerotic plaques in apolipoprotein E-knockout mice by combinatorial Toll-like receptor-1 and -2 gene silencing.
    Qi LH; Wang Y; Gao F; Zhang C; Ding SF; Ni M; Feng JB; Zhang Y
    Hum Gene Ther; 2009 Jul; 20(7):739-50. PubMed ID: 19278303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional characterization of naturally occurring genetic variants in the human TLR1-2-6 gene family.
    Ben-Ali M; Corre B; Manry J; Barreiro LB; Quach H; Boniotto M; Pellegrini S; Quintana-Murci L
    Hum Mutat; 2011 Jun; 32(6):643-52. PubMed ID: 21618349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aging disturbs the balance between effector and regulatory CD4+ T cells.
    van der Geest KS; Abdulahad WH; Tete SM; Lorencetti PG; Horst G; Bos NA; Kroesen BJ; Brouwer E; Boots AM
    Exp Gerontol; 2014 Dec; 60():190-6. PubMed ID: 25449852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.